The interiors of the COVAX and Dominican Republic contract

LIn addition to the first vacancies against Covid in the Dominican Republic, the principles of the implementation of the national evacuation plan, which establishes the hope of the end of the new coronavirus pandemic, will be established on an official basis.

Treated by “Covishield”, the carriage unveiled by the Anglo-Swedish pharmaceutical company AstraZeneca together with the University of Oxford in India, which was driven by a plane from Madrid and which had previously been towed to London by India .

This is the first dose lot that goes to the country, a 20 mile inoculations, of the more than 20 million that the Dominican Governor hopes to receive, being exactly the product of AstraZeneca and Oxford the most vacant, with 10 million.

This is followed by the product called “BNT162b2”, from the Pfizer stadium, realized in conjunction with the BioNTech biotechnology company, from the state of the state to acquire 7.9 million.

There are also 768,000 vacancies that will be purchased by the Chinese laboratory Sinovac, which is listed by the name “Coronavac”.

These are also summed up in the sums of the 2,169,600 doses administered by the presidential administration by Luis Abinader with the World Equitable Access Fund for the Vacancies against COVID-19 (COVAX), which is promoted by the World Health Organization Greetings (OMS) and administered by the Gavi Vacancy Alliance.

However, COVAX has a vehicle acquisition program and no pharmaceuticals like it, the Dominican Republic can receive various types of vehicles, depending on the availability of the vehicle.

For this reason, it is necessary to ask the following: What are the doses that the dose that is needed will work through this mechanism?

In agreement with the latest update of the COVAX Global Summarist forecast, our program has acquisition contracts with four distinct entities: AstraZeneca, Novavax, India Serum Institute (SII, by its English seal) and Johnson & Johnson, aunque with this ultimate is an agreement of no winner.

Cabe points out that Novavax’s “NVX-CoV2373” vaccine is in Phase 3 of clinical trials, which is the final test of inoculation prior to its approval.

At this stage the vaccine is administered for decades by healthy volunteers to determine if the vaccine protects the nurse, according to the body in charge of restoring the progress of anti-Covid vaccines.

Usually these statements are written to the persons with the mayor’s risk of counteracting the illness, and if the vacancy is demonstrated to be secure and effective during the trial, the regulatory agencies will review all evidence and determine whether it is approved or generalized. .

Johnson & Johnson has not yet been approved, but has submitted its applications for authorization to the European Union and the United States. According to its studies, it is effective at 66% in general and at 85% against the severe forms, and differs from the others, requiring only one application and no dosage.

Before these cases the COVAX mechanism does not integrate these amounts, have been approved by international sanitation agencies.

However, there is a possibility that this catalog will be expanded more than ever before, indicating that there are many bargains with other private companies and public bodies.

When do you read?

However, there is no specific record for the legacy of the first vacancies of the program, for which a species chronogram of entrees was announced.

Currently, the first cargo of vacancies has been deployed in Dominican territory with 542,400 doses of AstraZeneca, according to a report by the Panamericana de la Salud (OPS).

It was announced that COVAX would notify Latin American health authorities in the final months of this year, regarding the estimated dose of dosing for the first phase of evacuation.

Dicha information was received by 36 countries and territories participating in COVAX, between the Dominican Republic, estimating that the vacancies enrolled in the list will be from the second half of this month, the second quarter of 2021.

The contract

A total of $ 22,889,280 (more than 1,300 million pesos), distributions and dosages: an amount of US $ 3,471,360 (RD $ 201,338,880) and a guarantee of US $ 19,417,920 (already RD $ 1,126 .239,360). The initiative was paid, it was announced that it would be made before 9 October 2020.

The contract between the country and the Gavi alliance is a compromise agreement, one of the three options that will cover the referendum organization, since the other two pages are related and exclusionary.

Además el Gobierno podium elegir la cantidad de vacunas que quisieran, hasta cierto punto. The parameters between a number of vacancies to cover 50 and 10 per cent of the dominant population, with the national authorities decanting for this ultimate figure.

For the type of agreement chosen the Gobierno will demand the amount of the dose, assigned to the real price agreed with the manufacturer, with the salvage of which the price is more than the total payment paid, the participants pay less than the guarantee finance pactada, and can opt for the warranty of the warranty or require additional dose volumes, if available.

However, if the price is higher than the price with all inclusive, the participants only compromise to pay the total amount of the established in the compromise agreement, even less than the coverage of the indicated population, per the option of acquire the required amount at an additional cost.

SEPA MÁS

Sales

The sales that present a compromise purchase agreement are, for the most part, two.

The first is the relatively low cost of payment due to the reduced financial risk, and the remaining payments are directly linked to the dose.

However, the ability to resell the acquisition of vacancies at such a high cost, at the time of joining the mechanism.

The other types of agreements have a low cost financial guarantee, as well as a decision to make vacant candidates determined to be part of the mechanism.

.Source